Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling

Journal of Molecular and Cellular Cardiology

Volumn 77, Issue , 2014, Pages 113-124

  Chen, Yu ^a,b   Wakili, Reza ^a,c   Xiao, Jiening ^a   Wu, Chia Tung ^a,d   Luo, Xiaobin ^a   Clauss, Sebastian ^c   Dawson, Kristin ^a,b   Qi, Xiaoyan ^a   Naud, Patrice ^a   Shi, Yan Fen ^a   Tardif, Jean Claude ^a   Kääb, Stefan ^c   Dobrev, Dobromir ^e   Nattel, Stanley ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Fibrosis; Heart failure; MicroRNA; Remodeling

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 133B; MICRORNA 146A; MICRORNA 146B; MICRORNA 208A; MICRORNA 208B; MICRORNA 21; MICRORNA 214; MICRORNA 218; MICRORNA 222; MICRORNA 26A; MICRORNA 26B; MICRORNA 29B; MICRORNA 30A; UNCLASSIFIED DRUG; COLLAGEN TYPE 1; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CELL SELECTION; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; DISEASE DURATION; EXPERIMENTAL HEART FAILURE; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; HEART ATRIUM FIBRILLATION; HEART ATRIUM REMODELING; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE PACING; HEART VENTRICLE REMODELING; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; ANTIBODY SPECIFICITY; DOG; GENETICS; HEART ARRHYTHMIA; HEART ATRIUM; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE; METABOLISM; PATHOLOGY;

ANIMALS; ARRHYTHMIAS, CARDIAC; COLLAGEN TYPE I; DOGS; EXTRACELLULAR MATRIX; FIBROBLASTS; HEART ATRIA; HEART FAILURE; HEART VENTRICLES; MICRORNAS; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; TRANSCRIPTOME; VENTRICULAR REMODELING;

EID: 84908447891     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.10.001     Document Type: Article

References (35)

1. Oliveira-Carvalho V., Silva M.M., Guimarães G.V., Bacal F., Bocchi E.A. MicroRNAs: new players in heart failure. Mol Biol Rep 2013, 40:2663-2670.
2. Li D., Fareh S., Leung T.K., Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999, 100:87-95.
3. Barth A.S., Merk S., Arnoldi E., Zwermann L., Kloos P., Gebauer M., et al. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ Res 2005, 96:1022-1029.
4. Cardin S., Pelletier P., Libby E., Le Bouter S., Xiao L., Kaab S., et al. Marked differences between atrial and ventricular gene-expression remodeling in dogs with experimental heart failure. J Mol Cell Cardiol 2008, 45:821-831.
5. Cardin S., Libby E., Pelletier P., Le Bouter S., Shiroshita-Takeshita A., Le Meur N., et al. Contrasting gene expression profiles in two canine models of atrial fibrillation. Circ Res 2007, 100:425-433.
6. Divakaran V., Mann D.L. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 2008, 103:1072-1083.
7. Burstein B., Libby E., Calderone A., Nattel S. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 2008, 117:1630-1641.
8. Tijsen A.J., Pinto Y.M., Creemers E.E. Non-cardiomyocyte microRNAs in heart failure. Cardiovasc Res 2012, 93:573-582.
9. Qi X.Y., Yeh Y.H., Xiao L., Burstein B., Maguy A., Chartier D., et al. Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res 2008, 103:845-854.
10. Dawson K., Wu C.T., Qi X.Y., Nattel S. Congestive heart failure effects on atrial fibroblast phenotype: differences between freshly-isolated and cultured cells. PLoS One 2012, 7:e52032.
11. Cardin S., Li D., Thorin-Trescases N., Leung T.K., Thorin E., Nattel S. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 2003, 60:315-325.
12. Hanna N., Cardin S., Leung T.K., Nattel S. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res 2004, 63:236-244.
13. Shinbane J.S., Wood M.A., Jensen D.N., Ellenbogen K.A., Fitzpatrick A.P., Scheinman M.M. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997, 29:709-715.
14. Dorn G.W. MicroRNAs in cardiac disease. Transl Res 2011, 157:226-235.
15. Topkara V.K., Mann D.L. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther 2011, 25:171-182.
16. Duisters R.F., Tijsen A.J., Schroen B., Leenders J.J., Lentink V., van der Made I., et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009, 104:170-178.
17. Zhang Z.H., Li J., Liu B.R., Luo C.F., Dong Q., Zhao L.N., et al. MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target. J Cardiovasc Pharmacol 2013, 62:312-319.
18. van Rooij E., Sutherland L.B., Thatcher J.E., DiMaio J.M., Naseem R.H., Marshall W.S., et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008, 105:13027-13032.
19. Bagnall R.D., Tsoutsman T., Shephard R.E., Ritchie W., Semsarian C. Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure. PLoS One 2012, 7:e44744.
20. Thum T., Galuppo P., Wolf C., Fiedler J., Kneitz S., van Laake L.W., et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007, 116:258-267.
21. Pedrotty D.M., Klinger R.Y., Kirkton R.D., Bursac N. Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. Cardiovasc Res 2009, 83:688-697.
22. Spinale F.G., Janicki J.S., Zile M.R. Membrane-associated matrix proteolysis and heart failure. Circ Res 2013, 112:195-208.
23. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984.
24. Cardin S., Guasch E., Luo X., Naud P., Le Quang K., Shi Y., et al. Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure. Circ Arrhythm Electrophysiol 2012, 5:1027-1035.
25. Adam O., Löhfelm B., Thum T., Gupta S.K., Puhl S.L., Schäfers H.J., et al. Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res Cardiol 2012, 107:278.
26. Harada M., Luo X., Qi X.Y., Tadevosyan A., Maguy A., Ordog B., et al. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 2012, 126:2051-2064.
27. Adam O., Lavall D., Theobald K., Hohl M., Grube M., Ameling S., et al. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J Am Coll Cardiol 2010, 55:469-480.
28. Dawson K., Wakili R., Ordög B., Clauss S., Chen Y., Iwasaki Y., et al. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 2013, 127:1466-1475.
29. Sayed D., Hong C., Chen I.Y., Lypowy J., Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007, 100:416-424.
30. Yue L., Xie J., Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 2011, 89:744-753.
31. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
32. Qin W., Chung A.C., Huang X.R., Meng X.M., Hui D.S., Yu C.M., et al. TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 2011, 22:1462-1474.
33. Burstein B., Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008, 51:802-809.
34. Kim G.H. MicroRNA regulation of cardiac conduction and arrhythmias. Transl Res 2013, 161:381-392.
35. Harada M., Luo X., Murohara T., Yang B., Dobrev D., Nattel S. MicroRNA regulation and cardiac calcium signaling: role in cardiac disease and therapeutic potential. Circ Res 2014, 114:689-705.